|
|
Investigating Complement Component 3a Signaling in Viral Neuroinflammatory Responses. |
| 1 F30 AI157165-01A1 |
KANMOGNE, MARLENE |
NIAID |
2021 |
|
|
Design and development of HDAC11-specific chemical inhibitors for disease treatments |
| 1 R01 AI153110-01A1 |
SETO, EDWARD |
NIAID |
2021 |
|
|
Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis |
| 1 R01 AI156186-01A1 |
CIOFANI, MARIA |
NIAID |
2021 |
|
|
IL-37: a novel regulator of inflammation in CNS autoimmunity |
| 1 R01 AI160189-01 |
ROSTAMI, AM |
NIAID |
2021 |
|
|
TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammation |
| 1 R01 AI160774-01 |
WAN, YISONG |
NIAID |
2021 |
|
|
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis |
| 1 R01 AI161845-01 |
LI, HONGMIN |
NIAID |
2021 |
|
|
Innate immune regulation of neuroinflammation |
| 1 R01 AI162936-01 |
SONNENBERG, GREGORY F |
NIAID |
2021 |
|
|
Discovery of novel smHDAC8 inhibitors for the treatment of schistosomiasis |
| 1 R21 AI146512-01A1 |
PETUKHOV, PAVEL A |
NIAID |
2021 |
|
|
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS) |
| 1 R21 AI154772-01A1 |
MARKOVIC-PLESE, SILVA |
NIAID |
2021 |
|
|
Role of B cell interactions in CNS autoimmune demyelination |
| 1 R21 AI156123-01 |
BOYDEN, ALEXANDER |
NIAID |
2021 |
